Zevra Therapeutics(ZVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZVRA Zevra Therapeutics

盘后交易 01-12 19:00:34 EST

8.38

-0.11

-1.30%

盘后8.25

-0.13-1.55%

18:24 EST

最高8.61	最低8.08	成交量100.22万
今开8.57	昨收8.49	日振幅6.24%
总市值4.72亿	流通市值3.98亿	总股本5,630万
成交额826.50万	换手率2.11%	流通股本4,746万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ZVRA","market":"US","secType":"STK","nameCN":"Zevra Therapeutics","latestPrice":8.38,"timestamp":1768251600000,"preClose":8.49,"halted":0,"volume":1002173,"hourTrading":{"tag":"盘后","latestPrice":8.25,"preClose":8.38,"latestTime":"18:24 EST","volume":17821,"amount":149179.145475,"timestamp":1768260263807},"delay":0,"floatShares":47464900,"shares":56297535,"eps":0.591,"marketStatus":"盘后交易","change":-0.11,"latestTime":"01-12 19:00:34 EST","open":8.57,"high":8.61,"low":8.08,"amount":8264981.863553001,"amplitude":0.062426,"askPrice":8.66,"askSize":43,"bidPrice":8.31,"bidSize":50,"shortable":3,"etf":0,"ttmEps":0.591,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1768266000000},"marketStatusCode":4,"adr":0,"listingDate":1429156800000,"exchange":"NASDAQ","adjPreClose":8.49,"preHourTrading":{"tag":"盘前","latestPrice":8.42,"preClose":8.49,"latestTime":"09:09 EST","volume":2374,"amount":20045.726014,"timestamp":1768226995002},"postHourTrading":{"tag":"盘后","latestPrice":8.25,"preClose":8.38,"latestTime":"18:24 EST","volume":17821,"amount":149179.145475,"timestamp":1768260263807},"volumeRatio":1.234635,"impliedVol":0.933,"impliedVolPercentile":0.741},"requestUrl":"/m/hq/s/ZVRA","defaultTab":"news","newsList":[{"id":"1155322113","title":"Zevra Therapeutics签署分销协议，扩大尼曼匹克病C型治疗药物Miplyffa®的可及性","url":"https://stock-news.laohu8.com/highlight/detail?id=1155322113","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155322113?lang=zh_cn&edition=full","pubTime":"2025-12-29 20:30","pubTimestamp":1767011416,"startTime":"0","endTime":"0","summary":"Zevra Therapeutics（纳斯达克代码：ZVRA）今日宣布，公司已成功签署一项分销协议，旨在显著提升其核心产品Miplyffa®在治疗尼曼匹克病C型（NPC）领域的市场覆盖范围。该协议的落地预计将优化药物供应链，为更多NPC患者提供便捷的治疗选择。此次战略合作标志着Zevra Therapeutics在推动罕见病疗法普及方面迈出关键一步，有望进一步巩固其在专科治疗领域的市场地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZVRA"],"gpt_icon":0},{"id":"1122149310","title":"Zevra Therapeutics任命Timothy Sangiovanni为临时首席财务官 - SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1122149310","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122149310?lang=zh_cn&edition=full","pubTime":"2025-12-18 05:18","pubTimestamp":1766006289,"startTime":"0","endTime":"0","summary":"Zevra Therapeutics任命Timothy Sangiovanni为临时首席财务官 - SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVRA","BK4007"],"gpt_icon":0},{"id":"1100106090","title":"新闻发布：Zevra Therapeutics，Inc. 任命 Alicia Secor 为董事会成员；宣布 Wendy Dixon, PhD 决定退休","url":"https://stock-news.laohu8.com/highlight/detail?id=1100106090","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100106090?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:33","pubTimestamp":1764678829,"startTime":"0","endTime":"0","summary":"庆祝活动，佛罗里达州，2025年12月2日—— Zevra Therapeutics, Inc.是一家专注于为罕见疾病患者提供治疗的商业阶段公司，今天宣布任命 Alicia Secor 为公司董事会（董事会）成员。同时，公司还宣布董事 Wendy Dixon, PhD 的退休，立即生效。Zevra 董事会主席 Tamara A. Favorito 说。Secor 女士曾是 Orchard Therapeutics plc 的董事会成员，该公司是一家在美国纳斯达克市场上市的全球基因治疗公司，直至2024年1月被收购。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZVRA"],"gpt_icon":0},{"id":"1131964730","title":"Zevra Therapeutics, Inc. 任命 Alicia Secor 为董事会成员；宣布 Wendy Dixon, Phd 退休","url":"https://stock-news.laohu8.com/highlight/detail?id=1131964730","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131964730?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:30","pubTimestamp":1764678613,"startTime":"0","endTime":"0","summary":"Zevra Therapeutics, Inc. 任命 Alicia Secor 为董事会成员，并宣布 Wendy Dixon, Phd 退休。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVRA","BK4007"],"gpt_icon":0},{"id":"1187097867","title":"Zevra Therapeutics Inc：首席财务官 R. Laduane Clifton 将辞去职务","url":"https://stock-news.laohu8.com/highlight/detail?id=1187097867","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187097867?lang=zh_cn&edition=full","pubTime":"2025-11-21 05:06","pubTimestamp":1763672769,"startTime":"0","endTime":"0","summary":"Zevra Therapeutics Inc：首席财务官 R. Laduane Clifton 将辞去职务","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ZVRA"],"gpt_icon":0},{"id":"2561474957","title":"Zevra Therapeutics, Inc.盘中异动 早盘股价大涨6.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561474957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561474957?lang=zh_cn&edition=full","pubTime":"2025-08-21 22:36","pubTimestamp":1755787000,"startTime":"0","endTime":"0","summary":"北京时间2025年08月21日22时36分，Zevra Therapeutics, Inc.股票出现波动，股价大幅拉升6.30%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家专注于罕见病的公司，将科学、数据和患者需求相结合，为那些治疗选择有限或根本没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250821223640a6f398fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250821223640a6f398fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVRA","BK4139","BK4007","LENZ","BK4539"],"gpt_icon":0},{"id":"2559998888","title":"Zevra治疗公司营收增长26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559998888","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559998888?lang=zh_cn&edition=full","pubTime":"2025-08-13 22:36","pubTimestamp":1755095760,"startTime":"0","endTime":"0","summary":"罕见病药物开发商Zevra治疗公司（ZVRA）报告营收增长26%并完成1.5亿美元优先审评券（PRV）出售，显著增强了资产负债表实力。该公司正着力扩大市场覆盖范围并为持续进行的临床试验提供支持。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-08-13/doc-infkwfyp3812988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4007","ZVRA"],"gpt_icon":0},{"id":"1101320256","title":"异动解读 | Zevra Therapeutics股价盘中大跌12.76%，二季度业绩远低于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1101320256","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101320256?lang=zh_cn&edition=full","pubTime":"2025-08-13 21:32","pubTimestamp":1755091961,"startTime":"0","endTime":"0","summary":"8月13日周三，生物制药公司Zevra Therapeutics股价在盘中大幅下跌12.76%，主要原因是公司最新公布的第二季度财报显示业绩远低于市场预期。根据公司发布的财报，Zevra第二季度调整后每股收益为1.21美元，虽然高于去年同期的亏损0.48美元/股，但大幅低于分析师平均预期的1.50美元/股。公司营收同比增长481.7%至2588万美元，超过分析师预期的2254万美元。Zevra表示，截至2025年6月30日，公司持有现金2.177亿美元，拥有足够的资源和财务灵活性来执行战略重点。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZVRA"],"gpt_icon":0},{"id":"1164016053","title":"异动解读 | 业绩大幅低于预期，Zevra Therapeutics盘中重挫12.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=1164016053","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164016053?lang=zh_cn&edition=full","pubTime":"2025-08-13 21:32","pubTimestamp":1755091959,"startTime":"0","endTime":"0","summary":"生物制药公司Zevra Therapeutics周三盘中股价大跌12.76%，延续了盘前的跌势。这一显著下跌主要源于公司最新公布的第二季度财报显示业绩远低于市场预期。根据Zevra发布的财报，公司第二季度调整后每股收益为1.21美元，虽然高于去年同期的亏损0.48美元/股，但大幅低于分析师平均预期的1.50美元/股。这一走势反映出投资者对Zevra未来盈利能力的质疑，以及对生物制药行业整体前景的谨慎态度。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZVRA"],"gpt_icon":0},{"id":"1157949798","title":"异动解读 | Zevra Therapeutics盘前大跌10.80%，Q2业绩大幅低于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1157949798","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157949798?lang=zh_cn&edition=full","pubTime":"2025-08-13 16:14","pubTimestamp":1755072891,"startTime":"0","endTime":"0","summary":"生物制药公司Zevra Therapeutics今日盘前股价大跌10.80%，主要原因是公司最新公布的第二季度财报显示业绩远低于市场预期。根据公司发布的财报，Zevra第二季度调整后每股收益为1.21美元，虽然高于去年同期的亏损0.48美元/股，但大幅低于分析师平均预期的1.50美元/股。Zevra表示，截至2025年6月30日，公司持有现金2.177亿美元，拥有足够的资源和财务灵活性来执行战略重点。然而，盈利不及预期可能引发了市场对公司未来盈利能力的担忧，导致股价在盘前交易中大幅下跌。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZVRA"],"gpt_icon":0},{"id":"2517164643","title":"Zevra Therapeutics, Inc.盘中异动 早盘急速拉升5.06%报8.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517164643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517164643?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:44","pubTimestamp":1741275845,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时44分，Zevra Therapeutics, Inc.股票出现异动，股价急速拉升5.06%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306234405abeb89b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306234405abeb89b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ZVRA","BK4007"],"gpt_icon":0},{"id":"2514385254","title":"Zevra Therapeutics, Inc.盘中异动 快速拉升5.28%报7.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385254?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:32","pubTimestamp":1740666740,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时32分，Zevra Therapeutics, Inc.股票出现波动，股价大幅上涨5.28%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223220abdf6ece&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223220abdf6ece&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ZVRA","LENZ","BK4139"],"gpt_icon":0},{"id":"2508468381","title":"Zevra Therapeutics, Inc.盘中异动 快速拉升5.04%报8.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508468381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508468381?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:03","pubTimestamp":1738681413,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时03分，Zevra Therapeutics, Inc.股票出现异动，股价大幅拉升5.04%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204230333a2392f90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204230333a2392f90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVRA","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2485294101","title":"Zevra Therapeutics, Inc.盘中异动 快速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485294101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485294101?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:47","pubTimestamp":1732297662,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日01时47分，Zevra Therapeutics, Inc.股票出现波动，股价大幅上涨5.15%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123014742971a8271&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123014742971a8271&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","ZVRA","BK4139"],"gpt_icon":0},{"id":"2484677092","title":"Zevra Therapeutics, Inc.2024财年第三财季实现净利润-33.23百万美元，同比减少136.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484677092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484677092?lang=zh_cn&edition=full","pubTime":"2024-11-19 00:00","pubTimestamp":1731945627,"startTime":"0","endTime":"0","summary":"11月19日，Zevra Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-33.23百万美元，同比减少136.51%；其中营业收入为3.70百万美元，同比增加27.59%，每股基本收益为-0.70美元。从资产负债表来看，Zevra Therapeutics, Inc.总负债1.22亿美元，其中短期债务540000.00美元，资产负债比为1.58，流动比率为2.89。机构评级：截至2024年11月19日，当前有7家机构对Zevra Therapeutics, Inc.目标价做出预测，其中目标均价为20.14美元，其中最低目标价为15.00美元，最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000036a2435260&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000036a2435260&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ZVRA"],"gpt_icon":0},{"id":"2483385833","title":"Zevra Therapeutics, Inc.盘中异动 急速上涨5.08%报9.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483385833","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483385833?lang=zh_cn&edition=full","pubTime":"2024-11-15 02:15","pubTimestamp":1731608114,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日02时15分，Zevra Therapeutics, Inc.股票出现异动，股价大幅拉升5.08%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115021514a2384cbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115021514a2384cbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVRA","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2483884503","title":"Zevra Therapeutics, Inc.盘中异动 快速跳水5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483884503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483884503?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:30","pubTimestamp":1731508245,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时30分，Zevra Therapeutics, Inc.股票出现异动，股价急速下跌5.83%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322304698e42584&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322304698e42584&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","ZVRA","BK4139"],"gpt_icon":0},{"id":"2473258105","title":"Zevra Therapeutics, Inc.盘中异动 早盘大幅拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473258105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473258105?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:37","pubTimestamp":1728308262,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时37分，Zevra Therapeutics, Inc.股票出现异动，股价快速上涨5.14%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721374398e3ad93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721374398e3ad93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","ZVRA"],"gpt_icon":0},{"id":"2470110086","title":"Zevra Therapeutics, Inc.盘中异动 股价大跌6.84%报6.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470110086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470110086?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:37","pubTimestamp":1727444237,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日21时37分，Zevra Therapeutics, Inc.股票出现异动，股价快速下跌6.84%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927213717ab6682b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927213717ab6682b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","ZVRA"],"gpt_icon":0},{"id":"2468662514","title":"Zevra Therapeutics, Inc.盘中异动 快速拉升5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468662514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468662514?lang=zh_cn&edition=full","pubTime":"2024-09-20 21:30","pubTimestamp":1726839050,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日21时30分，Zevra Therapeutics, Inc.股票出现波动，股价快速上涨5.99%。Zevra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Zevra Therapeutics, Inc.公司简介：Zevra Therapeutics Inc 是一家研究罕见病的公司，融合科学、数据和患者需求，为治疗选择有限或没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202130509719c006&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409202130509719c006&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ZVRA","BK4007","BK4139"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.zevra.com","stockEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":0.0047},{"period":"3month","weight":-0.2289},{"period":"6month","weight":-0.3224},{"period":"1year","weight":-0.0047},{"period":"ytd","weight":-0.0525}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0629},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1774},{"period":"ytd","weight":0.0178}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Zevra Therapeutics, Inc.于2006年10月，在爱荷华州注册成立，并在2014年5月于特拉华州重组。该公司是一家罕见病公司，将科学、数据和患者需求结合起来，为治疗选择有限或没有治疗选择的疾病创造转化疗法。该公司的使命是为患有罕见疾病的人带来改变生活的疗法。凭借独特的、数据驱动的开发和商业化战略，该公司正在克服复杂的药物开发挑战，为罕见病社区提供新疗法。该公司拥有多样化的产品组合和候选产品，其中包括临床前开发计划、临床阶段管道和商业阶段资产。该公司团队拥有专业知识，并在通过平衡科学和数据与患者需求的方法推进面临复杂临床和监管挑战的有前途的疗法方面有着成功的记录。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.023204},{"month":2,"riseRate":0.6,"avgChangeRate":0.050169},{"month":3,"riseRate":0.2,"avgChangeRate":-0.051968},{"month":4,"riseRate":0.3,"avgChangeRate":-0.034233},{"month":5,"riseRate":0.529412,"avgChangeRate":-0.02501},{"month":6,"riseRate":0.7,"avgChangeRate":0.030108},{"month":7,"riseRate":0.454545,"avgChangeRate":0.018183},{"month":8,"riseRate":0.545455,"avgChangeRate":0.07256},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.025126},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.086846},{"month":11,"riseRate":0.454545,"avgChangeRate":0.046882},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.02796}],"exchange":"NASDAQ","name":"Zevra Therapeutics","nameEN":"Zevra Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zevra Therapeutics(ZVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zevra Therapeutics(ZVRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zevra Therapeutics,ZVRA,Zevra Therapeutics股票,Zevra Therapeutics股票老虎,Zevra Therapeutics股票老虎国际,Zevra Therapeutics行情,Zevra Therapeutics股票行情,Zevra Therapeutics股价,Zevra Therapeutics股市,Zevra Therapeutics股票价格,Zevra Therapeutics股票交易,Zevra Therapeutics股票购买,Zevra Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zevra Therapeutics(ZVRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zevra Therapeutics(ZVRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}